COMMUNIQUÉS West-GlobeNewswire

SS Innovations Launches Groundbreaking Inaugural Multi-Specialty Robotic Surgical Conference
22/01/2024
SMRSC 2024 brings global medical experts and technological innovators together to explore the future of robotic surgery 13 Live, broadcasted surgeries were performed by distinguished multi-specialty surgeons, using the [...]
Nusano Names Rohan Jain as Commercial General Manager
22/01/2024
VALENCIA, Calif., Jan. 22, 2024 (GLOBE NEWSWIRE) -- Nusano, a physics company transforming the production of medical radioisotopes, today announced Rohan Jain as its Commercial General Manager. Jain and his team will [...]
Virios Therapeutics Announces Plans to Advance Development of IMC-2 as Treatment for Symptoms Associated with Long-COVID
22/01/2024
- Placebo-Controlled Clinical Proof of Concept Data Expected in Mid-2024 - - Targeting Initiation of IMC-2 Phase 2 program in 2H 2024 - ATLANTA, Jan. 22, 2024 (GLOBE NEWSWIRE) -- Virios Therapeutics, Inc. (Nasdaq: VIRI [...]
AIM ImmunoTech Announces that the First Subject is Enrolled in the Phase 1b/2 Study Evaluating Ampligen® in Combination with AstraZeneca’s Imfinzi® for the Treatment of Late-Stage Pancreatic Cancer
22/01/2024
First enrollment takes place at Erasmus Medical Center in Rotterdam, Netherlands OCALA, Fla., Jan. 22, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced that the [...]
Pressure BioSciences Announces Closing of Uncle Bud’s Acquisition in All-Stock Transaction, Completing UltraShear Nanoemulsions Forward Integration with World Class Marketing & Sales
22/01/2024
Merged Companies Will Introduce Revolutionary New Product Capabilities Across Multiple Major Market Sectors, Expecting 2024 Revenues of Over $10 Million, Then Accelerating in Future Years SOUTH EASTON, Mass., Jan. 22, [...]
DGP Plc Takes Drug Testing In-house with Fingerprint Sweat-based Testing
22/01/2024
Construction logistics, security, and support specialist selects Intelligent Fingerprinting Drug Screening System to simplify and speed up workplace drug testing for its 450 employees and contractors “By using [...]
Biodexa CEO Issues Shareholder Letter Highlighting Progress in 2023 and Expected Milestones in 2024
22/01/2024
Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company”) Biodexa CEO Issues Shareholder Letter Highlighting Progress in 2023 and Expected Milestones in 2024 CARDIFF, United Kingdom, Jan. 22, 2024 (GLOBE NEWSWIRE) – [...]
ORIC Pharmaceuticals Announces $125 Million Private Placement Financing
22/01/2024
Funding from new and existing investors including Viking Global Investors, Commodore Capital, Frazier Life Sciences, Venrock Healthcare Capital Partners, New Enterprise Associates (NEA), and Nextech Pro forma cash and [...]
RespireRx Pharmaceuticals Inc. Announces the Appointment of Dr. Dariusz Naziek to Its Board of Directors
22/01/2024
Glen Rock, N.J., Jan. 22, 2024 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc. (OTC Pink Market:RSPI) (“RespireRx” or the “Company”), a leader in the discovery and development of innovative and revolutionary [...]
3Daughters Successfully Closes Over $2 million in First Tranche of Seed Financing Round
22/01/2024
Funding will accelerate development of a Novel IUD for contraception for IND filing in 2024 MANSFIELD, Mass., Jan. 22, 2024 (GLOBE NEWSWIRE) -- 3Daughters , a clinical development company fueling evolutionary healthcare [...]
ReiThera Srl, The Ragon Institute and IAVI Announce Collaboration to Advance Highly Networked T Cell HIV Vaccine Candidate Towards Phase I Clinical Evaluation
22/01/2024
Novel HIV vaccine candidate based on Gorilla adenoviral vector (GRAd-HIV) funded by the Bill & Melinda Gates Foundation to alleviate the disease burden and improve the lives of the millions who lack access to [...]
Taysha Gene Therapies Announces Poster Presentation on TSHA-102 in Rett Syndrome at Upcoming British Paediatric Neurology Association 2024 Annual Conference
22/01/2024
DALLAS, Jan. 22, 2024 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA), a clinical-stage gene therapy company focused on developing and commercializing AAV-based gene therapies for the treatment of [...]
Lumanity Reorganizes and Expands Strategic Consulting Capabilities
22/01/2024
Lumanity Reorganizes and Expands Strategic Consulting Capabilities Realigning global, clinical, regulatory, medical, and commercial consulting expertise to facilitate life science clients’ complex commercialization [...]
DLH to Announce Fiscal 2024 First Quarter Financial Results
22/01/2024
ATLANTA, Jan. 22, 2024 (GLOBE NEWSWIRE) -- DLH Holdings Corp. (NASDAQ: DLHC) (“DLH” or the “Company”), a leading healthcare and human services provider to the federal government, will release financial results for the [...]
Aclarion Expands Nociscan Access Into Phoenix With Key Opinion Leader Surgeon Advisor Juan Uribe, MD
22/01/2024
Dr. Uribe is Chief of the Division of Spinal Disorders, Volker K. H. Sonntag Chair of Spine Research, and Vice Chairman of Neurosurgery at Barrow Neurological Institute Dr. Uribe Becomes Aclarion’s 3 rd KOL With Access [...]
Palmetto Pharm Selects Inovalon ScriptMed® To Improve Patient Outcomes and Streamline Operations
22/01/2024
Inovalon's ScriptMed® Specialty Cloud-Based SaaS Solution Provides Data-Driven Analytics to Streamline Processes and Optimize Patient, Financial Outcomes BOWIE, Md., Jan. 22, 2024 (GLOBE NEWSWIRE) -- Inovalon , a [...]
Biora Therapeutics Announces Participation in Fireside Chat Hosted by H.C. Wainwright & Co.
22/01/2024
SAN DIEGO, Jan. 22, 2024 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc . (Nasdaq: BIOR), the biotech company that is reimagining therapeutic delivery, today announced participation in a virtual fireside chat hosted by H.C [...]
Madrigal Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
22/01/2024
CONSHOHOCKEN, Pa., Jan. 22, 2024 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a clinical-stage biopharmaceutical company pursuing novel therapeutics for nonalcoholic steatohepatitis (NASH), today [...]
SIRPant Immunotherapeutics Strengthens Board of Directors with Appointment of Roger Sawhney, M.D.
22/01/2024
HUMMELSTOWN, Pa., Jan. 22, 2024 (GLOBE NEWSWIRE) -- SIRPant Immunotherapeutics, Inc., a clinical-stage immuno-oncology company focusing on developing next-generation macrophage-based immunotherapies for the treatment of [...]

Pages